Lipidomic analysis of the liver from high-fat diet induced obese mice identifies changes in multiple lipid classes

Experimental and Molecular Pathology

Volumn 97, Issue 1, 2014, Pages 37-43

  Eisinger, Kristina ^a   Krautbauer, Sabrina ^a   Hebel, Tobias ^a   Schmitz, Gerd ^a   Aslanidis, Charalampos ^a   Liebisch, Gerhard ^a   Buechler, Christa ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Fatty acids; Lipidomic profiling; Obesity; Phospholipids

Indexed keywords

ABC TRANSPORTER A1; CERAMIDE; CHOLESTEROL; INTERLEUKIN 8; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PLASMALOGEN; SPHINGOMYELIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FATTY LIVER; IMMUNOBLOTTING; LIPID ANALYSIS; LIPID COMPOSITION; LIPID DIET; LIPIDOMICS; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; OBESITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

FATTY ACIDS; LIPIDOMIC PROFILING; OBESITY; PHOSPHOLIPIDS;

ALPHA-LINOLENIC ACID; ANIMALS; CHOLESTEROL; DECANOIC ACIDS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FATTY LIVER; LAURIC ACIDS; LIPID METABOLISM; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; PLASMALOGENS; SPHINGOMYELINS;

EID: 84901320675     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.05.002     Document Type: Article

References (55)

1. Allard J.P., et al. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J. Hepatol. 2008, 48:300-307.
2. An Y., et al. High-fat diet induces dynamic metabolic alterations in multiple biological matrices of rats. J. Proteome Res. 2013, 12:3755-3768.
3. Arendt B.M., et al. Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine. Appl. Physiol. Nutr. Metab. 2013, 38:334-340.
4. Barber M.N., et al. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS ONE 2012, 7:e41456.
5. Basciano H., et al. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E462-E473.
6. Bass N.M. Lipidomic dissection of nonalcoholic steatohepatitis: moving beyond foie gras to fat traffic. Hepatology 2010, 51:4-7.
7. Bjermo H., Riserus U. Role of hepatic desaturases in obesity-related metabolic disorders. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13:703-708.
8. Braverman N.E., Moser A.B. Functions of plasmalogen lipids in health and disease. Biochim. Biophys. Acta 2012, 1822:1442-1452.
9. Buechler C., Bauer S. ATP binding cassette transporter A1 (ABCA1) associated proteins: potential drug targets in the metabolic syndrome and atherosclerotic disease?. Curr. Pharm. Biotechnol. 2012, 13:319-330.
10. Buechler C., et al. Adiponectin, a key adipokine in obesity related liver diseases. World J. Gastroenterol. 2011, 17:2801-2811.
11. Cintra D.E., et al. Reversion of hepatic steatosis by exercise training in obese mice: the role of sterol regulatory element-binding protein-1c. Life Sci. 2012, 91:395-401.
12. Cortez-Pinto H., et al. How different is the dietary pattern in non-alcoholic steatohepatitis patients?. Clin. Nutr. 2006, 25:816-823.
13. Donnelly K.L., et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 2005, 115:1343-1351.
14. Ecker J., et al. A rapid GC-MS method for quantification of positional and geometric isomers of fatty acid methyl esters. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2012, 897:98-104.
15. Eisinger K., et al. Lipidomic analysis of serum from high fat diet induced obese mice. Int. J. Mol. Sci. 2014, 15:2991-3002.
16. Fernandez Gianotti T., et al. Fatty liver is associated with transcriptional downregulation of stearoyl-CoA desaturase and impaired protein dimerization. PLoS ONE 2013, 8:e76912.
17. Frederico M.J., et al. Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice. Scand. J. Gastroenterol. 2011, 46:1381-1388.
18. Gorden D.L., et al. Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. PLoS ONE 2011, 6:e22775.
19. Hanke D., et al. A diet high in alpha-linolenic acid and monounsaturated fatty acids attenuates hepatic steatosis and alters hepatic phospholipid fatty acid profile in diet-induced obese rats. Prostaglandins Leukot. Essent. Fat. Acids 2013, 89:391-401.
20. Hardwick J.P. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem. Pharmacol. 2008, 75:2263-2275.
21. Ichi I., et al. Effect of dietary cholesterol and high fat on ceramide concentration in rat tissues. Nutrition 2007, 23:570-574.
22. Jennemann R., et al. Hepatic glycosphingolipid deficiency and liver function in mice. Hepatology 2010, 51:1799-1809.
23. Kim H.J., et al. Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J. Proteome Res. 2011, 10:722-731.
24. Kurek K., et al. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease. Liver Int. 2013, (in press).
25. Lee R.G., et al. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential. Circ. Res. 2004, 95:998-1004.
26. Li Z., Vance D.E. Phosphatidylcholine and choline homeostasis. J. Lipid Res. 2008, 49:1187-1194.
27. Li Z.Z., et al. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J. Biol. Chem. 2009, 284:5637-5644.
28. Liebisch G., et al. Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS). J. Lipid Res. 1999, 40:1539-1546.
29. Liebisch G., et al. High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm. Biochim. Biophys. Acta 2004, 1686:108-117.
30. Liebisch G., et al. High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). Biochim. Biophys. Acta 2006, 1761:121-128.
31. Liebisch G., et al. Shorthand notation for lipid structures derived from mass spectrometry. J. Lipid Res. 2013, 54:1523-1530.
32. Longato L., et al. High fat diet induced hepatic steatosis and insulin resistance: role of dysregulated ceramide metabolism. Hepatol. Res. 2012, 42:412-427.
33. Lorbek G., et al. Cytochrome P450s in the synthesis of cholesterol and bile acids-from mouse models to human diseases. FEBS J. 2012, 279:1516-1533.
34. Matyash V., et al. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 2008, 49:1137-1146.
35. Monteiro J., et al. Oils rich in alpha-linolenic acid independently protect against characteristics of fatty liver disease in the delta6-desaturase null mouse. Can. J. Physiol. Pharmacol. 2013, 91:469-479.
36. Nagao K., Yanagita T. Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome. Pharmacol. Res. 2010, 61:208-212.
37. Oresic M., et al. Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids. Diabetologia 2013, 56:2266-2274.
38. Osabe M., et al. Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet. Drug Metab. Dispos. 2008, 36:294-302.
39. Puri P., et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007, 46:1081-1090.
40. Puri P., et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009, 50:1827-1838.
41. Ronis M.J., et al. Medium chain triglycerides dose-dependently prevent liver pathology in a rat model of non-alcoholic fatty liver disease. Exp. Biol. Med. (Maywood) 2013, 238:151-162.
42. Russo G.L. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem. Pharmacol. 2009, 77:937-946.
43. Schmitz G., Ruebsaamen K. Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis 2010, 208:10-18.
44. Schneider C.A., et al. NIH image to ImageJ: 25years of image analysis. Nat. Methods 2012, 9:671-675.
45. Sengupta A., Ghosh M. Comparison of native and capric acid-enriched mustard oil effects on oxidative stress and antioxidant protection in rats. Br. J. Nutr. 2012, 107:845-849.
46. Song H., et al. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E17-E25.
47. Tanaka N., et al. Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology 2012, 56:118-129.
48. Vance J.E., Tasseva G. Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochim. Biophys. Acta 2013, 1831:543-554.
49. Wanninger J., et al. Lipidomic analysis of the liver identifies changes of major and minor lipid species in adiponectin deficient mice. Exp. Mol. Pathol. 2013, 94:412-417.
50. Wattacheril J., et al. Differential intrahepatic phospholipid zonation in simple steatosis and nonalcoholic steatohepatitis. PLoS ONE 2013, 8:e57165.
51. Xin P., et al. Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats. Food Chem. Toxicol. 2013, 52:12-18.
52. Yang Y., et al. Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells. Biochimie 2010, 92:958-963.
53. Zhao H., et al. Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice. Hepatology 2009, 50:85-93.
54. Zigmond E., et al. Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E72-E78.
55. Zou Y., et al. Effects of high dietary fat and cholesterol on expression of PPAR alpha, LXR alpha, and their responsive genes in the liver of apoE and LDLR double deficient mice. Mol. Cell. Biochem. 2009, 323:195-205.